Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKYLARK: Zuranolone in severe postpartum depression
NCT04442503Phase 3Completed
- Sponsor
- Biogen
- Start
- Jun 2020
- Primary completion
- Mar 2022
- Modality
- Allosteric Modulators
- Countries
- 3
01
Overview
A Phase 3 trial of zuranolone in postpartum depression (PPD), sponsored by Biogen. Started Jun 2020; status: completed.
02
Drugs
zuranolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT04442503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04442503.